Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 14351 - 14375 of 14758 in total

REP8839

REP8839 is a novel methionyl-tRNA synthetase (MetS) inhibitor being developed by Replidyne (GlaxoSmithKline licensed REP8839 to Replidyne in June of 2003).
Investigational

2,5-Dimethoxy-4-(n)-propylthiophenethylamine

Experimental
Illicit

Embutramide

Experimental
Illicit

4-Bromo-2,5-dimethoxyphenethylamine

Experimental
Illicit

SC-74020

Experimental

R048-8071

Experimental

N-Cyclohexyl-N'-(4-Iodophenyl)Urea

Experimental

N-Butyl-Benzenesulfonamide

Experimental

1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene

Experimental

3,5-Difluorobenzenesulfonamide

Experimental

[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid

Experimental

4-iodo-acetamido phenylboronic acid

Experimental

(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide

Experimental

N-[(1R,2R)-1,3-Dihydroxy-1-(4-nitrophenyl)-2-propanyl]acetamide

Experimental

PASBN

Experimental

2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione

Experimental

Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]

Experimental

N-(4-{2-[(3-chlorobenzyl)amino]ethyl}phenyl)thiophene-2-carboximidamide

Experimental

6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One

Experimental

Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]

Experimental

GW-3965

GW-3965 is a liver X receptor ligand.
Experimental

2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol

Experimental

4-Phenylbutylamine

Experimental

2,3-Difluorobenzyl Alcohol

Experimental

Phenethylamine

Experimental
Displaying drugs 14351 - 14375 of 14758 in total